Genetic testing ordered as part of medically necessary treatment qualifies for FSA reimbursement when prescribed by your healthcare provider
Additionally, semaglutide has been associated with reductions in cardiovascular risk factors, such as decreased blood pressure and cholesterol levels
Br J Pharmacol 173:20952110
Clinical Evidence for Women's Fat Loss Results A 12-week double-blind study published in the International Journal of Obesity examined AOD 9604 effects in 300 participants, with 187 women included in the analysis
However, semaglutide has dedicated cardiovascular outcome data from the SELECT trial showing a 20% reduction in major adverse cardiac events
These products are typically sold online, labeled "for research purposes only," and marketed through social media, forums, and peptide vendor websites